LCM
SUPN icon

Legato Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Legato Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Sell
11,482
-2,626
-19% -$126K 0.04% 495
2026
Q1 		$729K Sell
14,108
-515
-4% -$26.2K 0.07% 392
2025
Q4 		$727K Sell
14,623
-7,875
-35% -$383K 0.06% 444
2025
Q3 		$1.08M Buy
22,498
+1,273
+6% +$51.3K 0.12% 271
2025
Q2 		$669K Hold
21,225
– – 0.08% 381
2025
Q1 		$695K Sell
21,225
-6,209
-23% -$220K 0.09% 348
2024
Q4 		$992K Buy
27,434
+5,962
+28% +$210K 0.13% 299
2024
Q3 		$669K Hold
21,472
– – 0.08% 384
2024
Q2 		$574K Sell
21,472
-5,933
-22% -$172K 0.08% 407
2024
Q1 		$935K Buy
27,405
+5,933
+28% +$177K 0.11% 282
2023
Q4 		$621K Hold
21,472
– – 0.08% 367
2023
Q3 		$592K Sell
21,472
-837
-4% -$25.5K 0.09% 359
2023
Q2 		$671K Hold
22,309
– – 0.09% 354
2023
Q1 		$808K Hold
22,309
– – 0.15% 239
2022
Q4 		$796K Buy
+22,309
New +$775K 0.15% 231
2018
Q1 		– Sell
-21,344
Closed -$851K – 208
2017
Q4 		$851K Hold
21,344
– – 0.12% 159
2017
Q3 		$854K Hold
21,344
– – 0.13% 161
2017
Q2 		$920K Buy
21,344
+19,185
+889% +$683K 0.39% 71
2017
Q1 		$68K Hold
2,159
– – 0.08% 47
2016
Q4 		$54.5K Buy
+2,159
New +$48.2K 0.99% 46

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Legato Capital Management's SUPN Position: Q2 2026 in Review

Legato Capital Management reduced its Supernus Pharmaceuticals (SUPN) stake by 19% in Q2 2026, selling an estimated $126K and leaving 11,482 shares worth $534K. The position accounts for 0.04% of the portfolio, ranked #495.

Legato Capital Management first reported a position in SUPN in Q4 2016 and has held it in 20 quarters since. The position peaked at $1.08M in Q3 2025. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Legato Capital Management held 11,482 shares of Supernus Pharmaceuticals worth $534K as of Q2 2026.
  • Legato Capital Management sold 2,626 Supernus Pharmaceuticals shares in Q2 2026, an estimated $126K.
  • Supernus Pharmaceuticals made up 0.04% of Legato Capital Management's portfolio in Q2 2026, its #495 holding.
  • Legato Capital Management first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 20 quarters since.
  • Legato Capital Management's Supernus Pharmaceuticals position peaked at $1.08M in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.